Your Specialty Pharmacy Solutions Leader
 

Your Specialty Pharmacy Solutions Leader

Delivering high-touch support for complex oncology, cell and gene, and rare disease therapies.

Patients are at the heart of all we do.

Biologics is a specialty pharmacy leader that creates extraordinary experiences for oncology, cell and gene, and rare disease patients.

With over 30 years of expertise, we are committed to simplifying access to life-changing medications and delivering personalized clinical care that helps patients understand how to take their medication, manage side effects and achieve the best-possible outcomes.

How We Help

Patients

Compassionate, patient-centered care with expert clinical guidance, side-effect
management, adherence support, and financial aid.

Providers

Customized pharmacy solutions that seamlessly integrate with your workflow and elevate patient care.

Biopharma Partners

Innovative, nimble and collaborative solutions that drive access and reach to
patients.

Payers

Strategic cost management paired with industry-leading access and clinical excellence.

Dan W.

Dan W. shares his cancer journey and the relationship he formed with Biologics nurse and his “guardian angel,” Porscha Scales.

Larry H.

Larry H., blood cancer survivor, shares how the Biologics team helped to educate him on his therapy.

Karen I.

Karen I. talks about how she was reassured by the Biologics team during her ovarian cancer journey.

Teri Swepston

Teri Swepston, VP Provider Sales, shares her WHY.

Now Playing

Dan W.

Dan W.

Now Playing

Larry H.

Larry H.

Now Playing

Karen I.

Karen I.

Now Playing

Teri Swepston

Teri Swepston

View Our Inventory List
Biologics is proud to offer more than 200 therapies that represent the leading edge in treatment for cancer and rare and complex diseases.

News & Stories

Biologics Drug Launches

This is the card image's alt text
  • Biopharma
  • IBTROZI
  • Non-Small Cell Lung Cancer
  • oncology
  • RARE
  • rare disease
  • ROS1
  • Specialty pharmacy
  • taletrectinib

Cary, N.C. , June 11, 2025 – Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease […]

Read More

This is the card image's alt text
  • AbbVie
  • EMRELIS
  • Non-Small Cell Lung Cancer
  • rare disease
  • Specialty pharmacy
  • telisotuzumab vedotin-tllv)

Cary, N.C. , May 20, 2025 – Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease […]

Read More

This is the card image's alt text
  • AVMAPKI
  • avutometinib
  • defactinib
  • FAKZYNJA
  • KRAS
  • limited specialty pharmacy
  • Ovarian Cancer
  • RARE

Cary, N.C. , May 9, 2025 – Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease […]

Read More

This is the card image's alt text
  • atrasentan
  • Biologics
  • immunoglobulin A nephropathy
  • McKesson
  • oncology
  • RARE
  • Specialty pharmacy
  • VANRAFIA

CARY, N.C., April 3, 2025—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected […]

Read More

This is the card image's alt text
  • GOMEKLI
  • low-grade glioma
  • MEK inhibitor
  • mirdametinib
  • neurofibromatosis
  • oncology
  • plexiform neurofibromas
  • rare disease
  • Specialty pharmacy

CARY, N.C., FEBRUARY 18, 2025—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been […]

Read More

This is the card image's alt text
  • oncology
  • rare disease
  • Romvimza
  • Specialty pharmacy
  • Tenosynovial Giant Cell Tumor
  • vimseltinib

CARY, N.C., February 17, 2025—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been […]

Read More

This is the card image's alt text
  • Acute Lymphoid Leukemia
  • Acute Myeloid Leukemia
  • KMT2Amenin protein
  • lysine methyltransferase 2A gene
  • REVUFORJ (revumenib)

CARY, N.C., January 24, 2025—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected […]

Read More

This is the card image's alt text
  • Azurity Pharmaceuticals
  • Danziten
  • nilotinib
  • pediatric rare
  • Ph+ CML
  • Philadelphia chromosome
  • rare disease

CARY, N.C., December 6, 2024—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been […]

Read More

This is the card image's alt text

CARY, N.C., November 14, 2024—We are thrilled to announce a pivotal milestone for Biologics. As of today, we’ve gained access […]

Read More

This is the card image's alt text
  • brain cancer
  • IDH-mutant Diffuse Glioma
  • VORANIGO
  • vorasidenib

CARY, N.C., September 25, 2024—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease, was selected by […]

Read More

This is the card image's alt text
  • Hutchinson-Gilford Progeria Syndrome.
  • llonafarnib
  • oncology
  • rare disease
  • Zokinvy

CARY, N.C., September 10, 2024 –Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease, was selected […]

Read More

This is the card image's alt text
  • imetelstat
  • Myelodysplastic Syndromes
  • oncology
  • rare disease
  • RYTELO
  • telomerase inhibitor
  • transfusion-dependent anemia

CARY, N.C., September 9, 2024—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected […]

Read More

This is the card image's alt text
  • CAMCEVI
  • gonadotropin-releasing hormone (GnRH) agonist
  • injection emulsion
  • leuprolide
  • prostate cancer

CARY, N.C., June 19, 2024—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been […]

Read More

This is the card image's alt text

2025 National Association of Specialty Pharmacy (NASP) Annual Meeting & Expo

Biologics by McKesson Specialty Pharmacy is thrilled to be a Bronze level sponsor for the National Association of Specialty Pharmacy 2025 Annual Meeting and Expo September 14 -17, 2025, at the Gaylord Rockies in Denver, CO.